Rhodes Jason P

DirectorDyne Therapeutics, Inc. (DYN) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$10.7M
Net Open-Market Flow
-$10.7M
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Sell(S)103K$21.14$2.2M4.5M
Jun 29, 2026Sell(S)52K$21.14$1.1M1.3M
Jun 29, 2026Sell(S)41K$21.14$860K976K
Jun 26, 2026Sell(S)163K$21.28$3.5M4.6M
Jun 26, 2026Sell(S)82K$21.28$1.7M1.4M
Jun 26, 2026Sell(S)64K$21.28$1.4M1.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001577014-26-000012) within minutes of acceptance. Every field above traces to the original document. Verify it directly: